April 17, 2024
Stocks & Bonds
[STOCK WATCH] Samjin Pharmaceutical falls 1.96%
[THE INVESTOR] As of Aug. 4 02:25 P.M., Samjin Pharmaceutical declined 1.96%, compared with yesterday, to 32,450 won. It had declined 2.41% through the past month. Standard deviation, which indicates variableness, records 1.4% over the same period of time over one month.
Compared with its close competitors within the same industry, KOSPI, Samjin Pharmaceutical was not only satisfactory in investment return among its peer group, but its volatility was also relatively good. Over the recent month, the return-on-risk, the return on investment with consideration about risk, was -1.7%. In spite of stock price decline, low volatility lead the return-on-risk to a high level. However, compared with the KOSPI industry, the return-on-risk is below the industrial mean, 0.6, and thus the industrial comparison performance was not so good.
By HeRo (hero@heraldcorp.com)
This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp.
Compared with its close competitors within the same industry, KOSPI, Samjin Pharmaceutical was not only satisfactory in investment return among its peer group, but its volatility was also relatively good. Over the recent month, the return-on-risk, the return on investment with consideration about risk, was -1.7%. In spite of stock price decline, low volatility lead the return-on-risk to a high level. However, compared with the KOSPI industry, the return-on-risk is below the industrial mean, 0.6, and thus the industrial comparison performance was not so good.
By HeRo (hero@heraldcorp.com)
This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp.
